Gastrointestinal Agents Concept

subject area of

• 10-biomarker algorithm to identify irritable bowel syndrome.  Academic Article
• A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease.  Academic Article
• A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon gamma antibody, in patients with moderate to severe Crohn's disease.  Academic Article
• A randomised placebo controlled trial of pegylated interferon alpha in active ulcerative colitis.  Academic Article
• A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study.  Academic Article
• ACG and CAG Clinical Guideline: Management of Dyspepsia.  Academic Article
• AST-120 (spherical carbon adsorbent) in the treatment of perianal fistulae in mild-to-moderate Crohn's disease: FHAST-1, a phase 3, multicenter, placebo-controlled study.  Academic Article
• Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial.  Academic Article
• An evidence-based systematic review on medical therapies for inflammatory bowel disease.  Academic Article
• An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews.  Academic Article
• Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial.  Academic Article
• Association between serum concentration of infliximab and efficacy in adult patients with ulcerative colitis.  Academic Article
• Austrian infliximab experience in Crohn's disease: a nationwide cooperative study with long-term follow-up.  Academic Article
• BDNF and PDE4, but not the GRPR, regulate viability of human medulloblastoma cells.  Academic Article
• C-reactive protein, an indicator for maintained response or remission to infliximab in patients with Crohn's disease: a post-hoc analysis from ACCENT I.  Academic Article
• Canadian Association of Gastroenterology Clinical Practice Guidelines: the use of infliximab in Crohn's disease.  Academic Article
• Change in erythrocyte mean corpuscular volume during combination therapy with azathioprine and infliximab is associated with mucosal healing: a post hoc analysis from SONIC.  Academic Article
• Cisapride: the problem of the heart.  Academic Article
• Clinical correlates of faecal incontinence in systemic sclerosis: identifying therapeutic avenues.  Academic Article
• Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: the Toronto consensus.  Academic Article
• Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab.  Academic Article
• Commonly used preparations for colonoscopy: efficacy, tolerability, and safety--a Canadian Association of Gastroenterology position paper.  Academic Article
• Current guidelines for dyspepsia management.  Academic Article
• Current guidelines on stress ulcer prophylaxis.  Academic Article
• Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn's Disease.  Academic Article
• Does smoking reduce infliximab's effectiveness against Crohn's disease?  Academic Article
• Does the treatment of gastroesophageal reflux disease (GERD) meet patients' needs? A survey-based study.  Academic Article
• Drug monitoring of biologics in inflammatory bowel disease.  Academic Article
• Dyspepsia.  Academic Article
• Dyspepsia.  Academic Article
• Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis.  Academic Article
• Economic evaluation of long-term management strategies for erosive oesophagitis.  Academic Article
• Efficacy and tolerability of tegaserod in constipation dominant irritable bowel syndrome.  Academic Article
• Eldelumab [Anti-IP-10] Induction Therapy for Ulcerative Colitis: A Randomised, Placebo-Controlled, Phase 2b Study.  Academic Article
• Eradication of Helicobacter pylori for non-ulcer dyspepsia.  Academic Article
• Eradication of Helicobacter pylori for non-ulcer dyspepsia.  Academic Article
• Eradication of Helicobacter pylori for non-ulcer dyspepsia.  Academic Article
• Eradication of helicobacter pylori for non-ulcer dyspepsia.  Academic Article
• Erythromycin for the prevention and treatment of feeding intolerance in preterm infants.  Academic Article
• Evolving concepts in functional gastrointestinal disorders: promising directions for novel pharmaceutical treatments.  Academic Article
• Exposure-efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn's Disease.  Academic Article
• Factors associated with changes in self-reported health status in infliximab-treated inflammatory bowel disease patients: results from a case management survey.  Academic Article
• Five-year Safety Data From ENCORE, a European Observational Safety Registry for Adults With Crohn's Disease Treated With Infliximab [Remicade®] or Conventional Therapy.  Academic Article
• Fontolizumab in moderate to severe Crohn's disease: a phase 2, randomized, double-blind, placebo-controlled, multiple-dose study.  Academic Article
• Gastro-oesophageal reflux disease.  Academic Article
• Gastro-oesophageal reflux disease.  Academic Article
• Gastro-oesophageal reflux disease.  Academic Article
• Impact of reference-based pricing for histamine-2 receptor antagonists and restricted access for proton pump inhibitors in British Columbia.  Academic Article
• Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism.  Academic Article
• Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection.  Academic Article
• Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: a retrospective observational study.  Academic Article
• Infliximab: lack of efficacy on perforating complications in Crohn's disease.  Academic Article
• Initial management strategies for dyspepsia.  Academic Article
• Initial management strategies for dyspepsia.  Academic Article
• Initial management strategies for dyspepsia.  Academic Article
• Initial management strategies for dyspepsia.  Academic Article
• Interstitial cells of Cajal as targets for pharmacological intervention in gastrointestinal motor disorders.  Academic Article
• Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial.  Academic Article
• Letter: Recommendations for the management of latent tuberculosis infection in IBD patients may not be applicable in all settings--author's reply.  Academic Article
• Letter: mucosal healing is associated with improved long-term outcomes in Crohn's disease - authors' reply.  Academic Article
• Long-term infliximab maintenance therapy for ulcerative colitis: the ACT-1 and -2 extension studies.  Academic Article
• Management of reflux-related symptoms.  Academic Article
• Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis.  Academic Article
• New pharmacologic approaches in gastroesophageal reflux disease.  Academic Article
• New pharmacologic approaches in gastroesophageal reflux disease.  Academic Article
• Pancreatic Enzyme Supplements Are Not Effective for Relieving Abdominal Pain in Patients with Chronic Pancreatitis: Meta-Analysis and Systematic Review of Randomized Controlled Trials.  Academic Article
• Pharmacological interventions for non-ulcer dyspepsia.  Academic Article
• Pharmacological interventions for non-ulcer dyspepsia.  Academic Article
• Pharmacological interventions for non-ulcer dyspepsia.  Academic Article
• Pharmacological interventions for non-ulcer dyspepsia.  Academic Article
• Phase II evaluation of anti-MAdCAM antibody PF-00547659 in the treatment of Crohn's disease: report of the OPERA study.  Academic Article
• Population pharmacokinetics-pharmacodynamics of vedolizumab in patients with ulcerative colitis and Crohn's disease.  Academic Article
• Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease - a SONIC post hoc analysis.  Academic Article
• Randomized controlled trial of sclerotherapy versus somatostatin infusion in the prevention of early rebleeding following acute variceal hemorrhage in patients with cirrhosis. Variceal Bleeding Study Group.  Academic Article
• Recommendations on chronic constipation (including constipation associated with irritable bowel syndrome) treatment.  Academic Article
• Response and remission are associated with improved quality of life, employment and disability status, hours worked, and productivity of patients with ulcerative colitis.  Academic Article
• Retesting for latent tuberculosis in patients with inflammatory bowel disease treated with TNF-α inhibitors.  Academic Article
• Review and clinical perspectives for the use of infliximab in ulcerative colitis.  Academic Article
• Review article: a clinician's guide for therapeutic drug monitoring of infliximab in inflammatory bowel disease.  Academic Article
• Review article: current treatment options and management of functional dyspepsia.  Academic Article
• Review article: defining remission in ulcerative colitis.  Academic Article
• Review article: infliximab for Crohn's disease treatment--shifting therapeutic strategies after 10 years of clinical experience.  Academic Article
• Should we step-up or step-down in the treatment of new-onset dyspepsia in primary care?  Academic Article
• Sudden cardiac death & the Reverse Dodo Verdict.  Academic Article
• Systematic Review and Meta-Analysis: Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory to Steroids.  Academic Article
• Systematic Review and Meta-Analysis: Preoperative Vedolizumab Treatment and Postoperative Complications in Patients with Inflammatory Bowel Disease.  Academic Article
• Systematic Review: Sequential Rescue Therapy in Severe Ulcerative Colitis: Do the Benefits Outweigh the Risks?  Academic Article
• Systematic review: Antacids, H2-receptor antagonists, prokinetics, bismuth and sucralfate therapy for non-ulcer dyspepsia.  Academic Article
• Systematic review: persistence and severity in gastro-oesophageal reflux disease.  Academic Article
• The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?  Academic Article
• The Real-World Effectiveness and Safety of Vedolizumab for Moderate-Severe Crohn's Disease: Results From the US VICTORY Consortium.  Academic Article
• The Second Canadian Gastroesophageal Reflux Disease Consensus: moving forward to new concepts.  Academic Article
• The effects of infliximab therapy on health-related quality of life in ulcerative colitis patients.  Academic Article
• The intestinal microbiome, probiotics and prebiotics in neurogastroenterology.  Academic Article
• The minimal detectable change cannot reliably replace the minimal important difference.  Academic Article
• The scientific and regulatory rationale for indication extrapolation: a case study based on the infliximab biosimilar CT-P13.  Academic Article
• Tracking gastrointestinal transit of solids in aged rats as pharmacological models of chronic dysmotility.  Academic Article
• Treatment Algorithm for Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome Derived from a Canadian National Survey and Needs Assessment on Choices of Therapeutic Agents.  Academic Article
• Update from the Canadian Dyspepsia Working Group.  Academic Article
• Update on pathogenesis and predictors of response of therapeutic strategies used in inflammatory bowel disease.  Academic Article
• Using the incremental net benefit framework for quantitative benefit-risk analysis in regulatory decision-making--a case study of alosetron in irritable bowel syndrome.  Academic Article
• Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.  Academic Article
• WITHDRAWN: Eradication of Helicobacter pylori for non-ulcer dyspepsia.  Academic Article
• WITHDRAWN: Initial management strategies for dyspepsia.  Academic Article
• WITHDRAWN: Pharmacological interventions for non-ulcer dyspepsia.  Academic Article
• Withdrawal of long-term maintenance treatment with azathioprine tends to increase relapse risk in patients with Crohn's disease.  Academic Article
• [Infliximab in the treatment of Crohn's disease -- a practical approach. Infliximab and chronic Crohn's disease--Consensus statement of the Working Group on Chronic Inflammatory Crohn's Diseases of the OGGH].  Academic Article
• [Infliximab therapy for Crohn's disease - a practical guideline: actualised consensus of the working group for chronic inflammatory bowel diseases of the Austrian Society for Gastroenterology and Hepatology].  Academic Article
• [Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management (Spanish version)].  Academic Article
• [Use of infliximab in ulcerative colitis].  Academic Article